Key facts
- This page summarizes Robert E. Landry's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
- 6 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Dec 2022, 15:05.
Robert E. Landry - 01 Dec 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)
- Reporting relationship
- EVP Finance CFO
- Issuer ticker
- REGN
- Reported as of
- 01 Dec 2022
- Net transaction value
- -$943,825
- SEC form
- 4
- Accepted by SEC
- 02 Dec 2022, 15:05:43 UTC
- Prior SEC filing
- 02 Nov 2022
- Next SEC filing
- 12 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/**Robert E. Landry
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert E. Landry filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 02 Dec 2022.
Change
- Previous filing in this sequence was filed on 02 Nov 2022.
- Current net transaction value: -$943,825.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
REGN
transaction
Common Stock
Options Exercise
- Transaction value
- $954,800
- Shares
- +2,500
- Change %
- +8.7%
- Price
- $381.92
- Shares after
- 31,244
- Date
- 01 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
REGN
transaction
Common Stock
Tax liability
- Transaction value
- $1,437,062
- Shares
- -1,890
- Change %
- -6%
- Price
- $760.35
- Shares after
- 29,354
- Date
- 01 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
REGN
transaction
Common Stock
Sale
- Transaction value
- $440,283
- Shares
- -582
- Change %
- -2%
- Price
- $756.50
- Shares after
- 28,772
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
REGN
transaction
Common Stock
Sale
- Transaction value
- $12,158
- Shares
- -16
- Change %
- -0.06%
- Price
- $759.90
- Shares after
- 28,756
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
REGN
transaction
Common Stock
Sale
- Transaction value
- $9,122
- Shares
- -12
- Change %
- -0.04%
- Price
- $760.19
- Shares after
- 28,744
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
REGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 250
- Date
- 01 Dec 2022
- Ownership
- By 401(k) Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
REGN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,500
- Change %
- -27%
- Price
- $0.000000
- Shares after
- 6,800
- Date
- 01 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $381.92
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Footnote F2
The stock option award vests in four equal annual installments, commencing one year after the date of grant.